Related Experiment Video

Updated: Jun 3, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

[Interventional revascularization for cardiovascular disease in patients with chronic kidney disease]

Hideki Ishii1, Toyoaki Murohara

  • 1Department of Cardiology, Nagoya University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 11, 2011
PubMed

Insights

Chronic kidney disease (CKD) increases cardiac mortality risk and restenosis after cardiovascular interventions like percutaneous coronary intervention (PCI). Managing atherosclerosis in CKD patients is challenging, but improved treatments may offer better outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Atherosclerosis Research

Context:

  • Chronic kidney disease (CKD) is a significant risk factor for cardiovascular mortality.
  • Patients with CKD exhibit accelerated atherosclerosis, complicating treatment.
  • Higher restenosis rates persist after percutaneous coronary intervention (PCI) and endovascular therapy (EVT) in CKD patients, even with advanced treatments.

Purpose:

  • To highlight the challenges in managing atherosclerotic disease in CKD patients.
  • To review recent advancements in devices and medical treatments for PCI and EVT in CKD.
  • To emphasize the predictive role of inflammatory markers like C-reactive protein in CKD outcomes.

Summary:

  • CKD independently elevates cardiac mortality risk and is associated with accelerated atherosclerosis.
  • Despite advancements like drug-eluting stents, restenosis rates remain high after PCI for coronary artery disease and EVT for peripheral artery disease in CKD patients.
  • Inflammatory markers, such as C-reactive protein, may predict adverse clinical outcomes, including restenosis, in this population.

Impact:

  • Improved understanding of the link between CKD and cardiovascular outcomes.
  • Informs the development of targeted therapies and improved device strategies for CKD patients undergoing revascularization.
  • Highlights the importance of monitoring inflammatory markers for risk stratification and management in CKD.

More Related Videos

Intravascular Delivery of Biologics to the Rat Kidney07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...